Quintiles (IQV): Analyst Target Range

Symbol and logo of brand IQVIA Holdings (IQV)

IQVIA Holdings Inc. (IQV) combines advanced IT analytics with the organization of medical trials, mitigating risks through a global customer reach. This price chart on the GURU.Markets platform captured the 314.76 metric. The company has created an indispensable digital environment that accelerates drug launches. Monopoly access to massive datasets and multi-year agreements ensure a reliable cash flow and high liquidity for the business.

Quintiles - IQV Price Target Chart (period 07/04/2022 - 11/15/2026)

Analytical breakdowns for Quintiles (IQV)

- price and consensus price forecast:
Fundamental company analysis:IQVIA Holdings, IQV
Finished products of IQVIA Inc.

The selection of defensive assets is based on the stability of cash flows, which is confirmed by the dominance of IQVIA Holdings Inc. (IQV) in the B2B medical data analytics segment and clinical trial management. The investment community's average benchmark synthesizes independent expert valuations into a single trajectory, allowing investors to filter out market noise and determine the fair value of the business based on long-term fundamental expectations.